SMI 10’522 -1.3%  SPI 13’134 -1.3%  Dow 30’932 -1.5%  DAX 13’786 -0.7%  Euro 1.0973 -0.4%  EStoxx50 3’636 -1.3%  Gold 1’734 -2.0%  Bitcoin 41’689 -2.4%  Dollar 0.9085 0.4%  Öl 66.0 -1.7% 

15.01.2020 14:00:00

We Be High Releases Free Cannabis Research Series - Enjoy Engaging, Medically Cited Publications Worldwide

IRVINE, Calif., Jan. 15, 2020 /PRNewswire/ -- We Be High – a global cannabis news and research portal – is excited to announce an engaging series on the cannabis plant in support of its federal legalization. The new series covers every important aspect related to cannabis, from legal issues to science, news, and lifestyle topics.

We Be High

"Federal legalization is coming to us sooner than later. Both hemp and marijuana have recently received great support from the American society. We want to prepare a legitimate educational background for everybody in the community, both people who are just entering the market and those who consider themselves seasoned consumers. Our website is based on the latest scientific research, as well as news from mainstream cannabis media. Our aim is to unite the cannabis consumers, not divide them in the classic hemp vs. marijuana way," says Dustin Marin, founder and CEO.

"I couldn't agree more. Cannabinoids are complicated, and we still have much to discover about the way it affects people despite being in use for almost 10,000 years," says cannabis researcher and consultant Justin Cooke, Editor in Chief at Daily CBD.

"Let's face it, cannabis science is something new to many people. Thirty years ago, hardly anyone knew about the endocannabinoid system, let alone the medical benefits of using cannabis. We can't expect people to understand everything while throwing weird-sounding scientific terms at their faces. We created We Be High to serve you that knowledge in an easily digestible way. The more people begin to understand the basics behind how cannabis affects us, the shorter our road to the federal legalization," emphasizes Cooke.

The engaging news and research series on cannabis allows users to educate themselves using a well-backed source of information, from understanding the plant's effects to its history, medical uses, influence on the contemporary culture to explaining the differences between various forms of cannabis.

To expand the knowledge about cannabis and learn to benefit from using the plant, on the recently released interactive global guides, readers find our series of cannabis news and research.

To keep up with the latest cannabis news and research – We Be High will provide readers with the latest unbiased, medically cited, and easy to consume objective product guides.

Media Contact: 

Dustin Marin – dustin@webehigh.com 

Related Images

free-global-cbd-medical-research.png
Free Global CBD Medical Research

full-spectrum-cbd-oil-vs-cbd.png
Full-Spectrum CBD Oil vs. CBD Isolate: What's the Difference?

the-ultimate-guide-to-cannabidiol.png
The Ultimate Guide to Cannabidiol (CBD)

Related Links

CBD Archives - We Be High

Introduction to CBD - We Be High

We Be High

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/we-be-high-releases-free-cannabis-research-series---enjoy-engaging-medically-cited-publications-worldwide-300987134.html

SOURCE We Be High

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Am 1. Februar 2020 startet Lucas Bruggeman als neuer CEO der BX Swiss AG in einem noch vollen Büro. Das änderte sich sehr schnell und das gesamte BX Swiss Team befand sich im Homeoffice. Heute bei BX Swiss TV zieht Lucas Bruggeman Bilanz von seinem ersten Jahr und gibt Einblicke was die Partner, Kunden, Privatanleger und Zuschauer in den nächsten Monaten erwarten können.

Lucas Bruggeman: Bilanz nach einem Jahr CEO an der BX Swiss | BX Swiss TV

Finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten
pagehit